Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
Neuron2010Vol. 67(2), pp. 199–212
Citations Over TimeTop 10% of 2010 papers
John P. Miller, Jennifer Holcomb, Ismael Al‐Ramahi, María de Haro, Juliette Gafni, Ningzhe Zhang, Eugene S. Kim, Mario Sanhueza, Cameron Torcassi, Seung Kwak, Juan Botas, Robert E. Hughes, Lisa Ellerby
Related Papers
- → Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington’s disease(2007)112 cited
- → Impaired mitochondrial trafficking in Huntington's disease(2009)67 cited
- → The calpain-suppressing effects of olesoxime in Huntington's disease(2016)15 cited
- → Recent Trends in Detection of Huntingtin and Preclinical Models of Huntington’s Disease(2014)5 cited
- Assessments of potential interactions of huntingtin-associated-protein-1 in the R6/2 mouse model of Huntington's disease(2004)